4.7 Article

Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris

Journal

MSYSTEMS
Volume 6, Issue 4, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/mSystems.00822-21

Keywords

Candida auris; Candida albicans; extracellular vesicles; multi-omics; fungal pathogenesis; candidiasis

Categories

Funding

  1. National Institutes of Health (NIH)National Institute of Allergy and Infectious Diseases [R21 AI124797]
  2. Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [311179/2017-7, 408711/2017-7]
  3. FAPERJ [E-26/202.809/2018]
  4. Brazilian Ministry of Health [440015/2018-9]
  5. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [405520/2018-2, 301304/2017-3]
  6. Fiocruz [PROEP-ICC 442186/2019-3, VPPCB-007-FIO-18, VPPIS-001-FIO18]
  7. Instituto Nacional de Ciencia e Tecnologia de Inovacao em Doencas de Populacoes Negligenciadas (INCT-IDPN)
  8. NIH [AI052733, AI15207, HL059842]

Ask authors/readers for more resources

Candida auris is a multidrug-resistant pathogenic fungus responsible for outbreaks worldwide, with its released extracellular vesicles (EVs) affecting adhesion to epithelial cells and immune response differently compared to Candida albicans EVs.
Candida auris is a recently described multidrug-resistant pathogenic fungus that is increasingly responsible for health care-associated outbreaks across the world. Bloodstream infections of this fungus cause death in up to 70% of cases. Aggravating this scenario, the disease-promoting mechanisms of C. auris are poorly understood. Fungi release extracellular vesicles (EVs) that carry a broad range of molecules, including proteins, lipids, carbohydrates, pigments, and RNA, many of which are virulence factors. Here, we carried out a comparative molecular characterization of C. auris and Candida albicans EVs and evaluated their capacity to modulate effector mechanisms of host immune defense. Using proteomics, lipidomics, and transcriptomics, we found that C. auris released EVs with payloads that were significantly different from those of EVs released by C. albicans. EVs released by C. auris potentiated the adhesion of this yeast to an epithelial cell monolayer, while EVs from C. albicans had no effect. C. albicans EVs primed macrophages for enhanced intracellular yeast killing, whereas C. auris EVs promoted survival of the fungal cells. Moreover, EVs from both C. auris and C. albicans induced the activation of bone marrow-derived dendritic cells. Together, our findings show distinct profiles and properties of EVs released by C. auris and by C. albicans and highlight the potential contribution of C. auris EVs to the pathogenesis of this emerging pathogen. IMPORTANCE Candida auris is a recently described multidrug-resistant pathogenic fungus that is responsible for outbreaks across the globe, particularly in the context of nosocomial infections. Its virulence factors and pathogenesis are poorly understood. Here, we tested the hypothesis that extracellular vesicles (EVs) released by C. auris are a disease-promoting factor. We describe the production of EVs by C. auris and compare their biological activities against those of the better-characterized EVs from C. albicans. C. auris EVs have immunoregulatory properties, of which some are opposite those of C. albicans EVs. We also explored the cargo and structural components of those vesicles and found that they are remarkably distinct compared to EVs from C. auris's phylogenetic relative Candida albicans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available